The Pharma Data

MARCH 29, 2023

Medicines reached a record 30 million people, driven by JARDIANCE® and OFEV® R&D investments of 5 billion EUR, or 21 percent of net sales Net sales rise 10.5 Medicines reached a record 30 million people, driven by JARDIANCE® and OFEV® R&D investments of 5 billion EUR, or 21 percent of net sales Net sales rise 10.5

Medicine 40

Medicine Sales Contract Manufacturing Production 40

The Pharma Data

MARCH 24, 2021

of net sales). Outlook 2021: slight year-on-year increase in net sales on a comparable basis. All of its businesses contributed positively to net sales and operating income. The company recorded net sales of 19.57 Foreign currency headwinds had a considerable impact; adjusted for currency effects, net sales rose by 5.6%

Sales 52

Sales Contract Manufacturing Medicine Antibody 52

pharmaphorum

JUNE 2, 2021

Capacity to supply Moderna’s COVID-19 vaccine in Europe could be swelled by round 300 million doses a year, following an agreement to set up a new production line at contract manufacturer Lonza. Full approval means it could be used routinely in future as an annual booster, much like the seasonal influenza vaccine.

Vaccination 52

Vaccination Vaccine Contract Manufacturing Production 52

The Pharma Data

DECEMBER 23, 2020

” Dr. Stanley Plotkin , Professor Emeritus at The Wistar Institute, said, “INOVIO’s DNA vaccine appeared to be quite safe with few significant reactions but yet induced both antibody and T cell responses to SARS-CoV-2.” . PLYMOUTH MEETING, Pa. , The participants were enrolled into 1.0

DNA 40

DNA Vaccination Vaccine Immune Response 40

Camargo

FEBRUARY 4, 2021

Report Shows that Most Drugs Fall Short of Sales Forecasts. Last month, LEK Consulting reported that more than half of the drugs rolled out since 2004 failed to live up to sales forecasts. For vaccines, the patient alone is involved in the risk assessment. The Agency refers to such facility as a Monograph Drug Facility (MDF).

Development 131

Development Production Drugs Manufacturing 131

The Pharma Data

JULY 29, 2021

Billion Doses Expected to be Delivered in 2021 Under Signed Contracts as of Mid-July 2021 – Raises Guidance Ranges Excluding BNT162b2(1) for Revenue by $400 Million and Adjusted Diluted EPS(3) by $0.05 Second-Quarter 2021 Revenues of $19.0 Raises Full-Year 2021 Guidance(4) for Revenues to a Range of $78.0 Total Oper.

Manufacturing 52

Manufacturing Sales Contract Manufacturing Vaccination 52

The Pharma Data

JANUARY 5, 2021

Novasep’s division expects to generate sales revenue of approximately 37 million euros in 2020 at double-digit profit margins and employs approximately 100 people, the majority of whom work at its Pompey site in northern France and some in the USA , China and India. In fiscal 2019, the company earned sales revenue of some 1.83

Life Science 52

Life Science Manufacturing Sales Contract Manufacturing 52

The Pharma Data

MAY 4, 2021

to $3.65, Primarily Reflecting Updates to Anticipated Contributions from BNT162b2 Partially Offset by Additional R&D Expenses for Vaccines to Protect Against COVID-19 as Well as Other mRNA-Based Development Programs and COVID-19 Antivirals. Billion Doses Expected to be Delivered in 2021 Under Signed Contracts as of Mid-April 2021.

Vaccination 40

Vaccination Vaccine Production Sales 40